Our Recommendations
- Laboratory manual for yellow fever (2024)
- Yellow fever laboratory diagnostic testing in Africa. Interim Guidance (2016)
- Preferred product characteristics for personal protective equipment for the health worker on the frontline responding to viral hemorrhagic fevers in tropical climates (2018)
- WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever (2025)
New Publications
- WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever (2025)
- Risk communication and community engagement readiness and response toolkit: yellow fever (2024)
- Performance of Certest Biotec’s VIASURE yellow fever real time PCR detection kit (2025)
- Laboratory manual for yellow fever (2024)
- Operational guidance on the use of yellow fever assays in the context of surveillance (2023)
Filter
27
Featured
Recommendations
4
New Publications
9
Language
Document type
No document type
11
Guidelines
7
Strategic & Response Plan
5
Manuals
2
Studies & Reports
1
Fact sheets
1
Countries / Regions
Global
4
Latin America and the Carribbean
2
Brazil
2
Sierra Leone
1
Guinea
1
Congo, Democratic Republic of
1
Liberia
1
Authors & Publishers
Publication Years
Toolboxes
Rapid Response
11
2.0 Rapid Response
6
Ebola & Marburg
1
NTDs
1
Zika
1
On a need’s basis, the Immunization Analysis and Insights, Vaccine Preventable Diseases (VPD) Surveillance and Risk Assessment Team of the World Health Organization (WHO) posts expression of interest (EOI) calls, inviting manufacturers of specified technologies (in vitro diagnostics also known as ...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers, and partners to plan and implement readiness and response activities for yellow fever outbreaks. The toolkit conta...
Las olas de transmisión de la fiebre amarilla ocurridas en la Región de las Américas entre el 2016 y el 2018 causaron el mayor número de casos humanos y epizoóticos registrados en varios decenios. La fiebre amarilla es una enfermedad hemorrágica viral grave que representa un desafío para el p...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
Technical document, update 2021
The EYE communication strategy is intended for use by all EYE partners and respective communication teams, as well as regional and country colleagues who will need to communicate about the work of EYE. It will also be publicly available for others, such as non-governmental organizations (NGOs) and p...
The scope of this PPC document is to serve as a guide to address the unmet public health need for a PPE system that protects the HW-F in tropical climate
s while caring for patients and providing heavy duty essential health services.
The characteristics described in this guidance are targeted fo...
The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives:
protect at-risk populations;
prevent international spread; and
contain outbreaks rapidly.
WHO Secretariat Information paper July 2016
July 2016
10 points from field experience
